This solution is compounded to provide unique concentrations of Nifedipine (0.2%, 0.3%, or 0.5%) as specified by a healthcare provider’s prescription.
- The medication is incorporated into a specialized Lanolin/Petrolatum vehicle that is engineered to act as a protective moisture barrier while maintaining the medication in direct contact with the targeted tissue.
- For patients requiring additional localized support, Lidocaine (5%) can be integrated into the ointment to offer a comprehensive, practitioner-customized preparation.
- This delivery system is specifically chosen to facilitate localized absorption through the mucosal lining while minimizing the systemic distribution often seen with oral calcium channel blockers.